Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Tessa Therapeutics
Singapore
C
101-250 Employees
2001
Key takeaway
Tessa Therapeutics is a biotechnology company focused on developing innovative allogeneic cell therapies for cancer, including a unique CD30-CAR EBVST platform that targets various cancers.
Reference
Core business
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
BioConnexUS
Singapore
C
1-10 Employees
2017
Key takeaway
The company focuses on developing market entry and localization strategies, which could be relevant for the introduction of bispecific antibodies in the US market through key opinion leaders and hospital systems.
Reference
Core business
Bioconnex US
CellVec Pte Ltd
Singapore
C
11-50 Employees
2018
Key takeaway
CellVec is a certified GMP gene therapy CDMO that specializes in providing custom viral vectors for pre-clinical and clinical applications. They utilize a lentivirus-based Vector Platform to enhance the production of viral vectors, which is crucial for the development of advanced therapies.
Reference
Core business
CellVec | Innovation for Patient Benefit
A certified GMP gene therapy CDMO that is a specialist provider of custom viral vectors for pre-clinical and clinical applications
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
The BioFactory Pte. Ltd.
Singapore
C
11-50 Employees
2010
Key takeaway
The Biofactory is a biomedical incubator in Singapore focused on the commercialization of innovative biomedical technologies, which may include developments like bispecific antibodies. With a strong commitment to quality and an experienced team, they provide essential support for successful biomedical start-ups.
Reference
Product
Companies | BioFactory
Advanced Cell Therapy and Research Institute Singapore
Singapore
C
51-100 Employees
2020
Key takeaway
ACTRIS is focused on advancing cellular-based therapeutics, including immunotherapy, through its commitment to process development and manufacturing. Their goal is to establish a Centre of Excellence that ensures quality compliance and facilitates the delivery of innovative therapies.
Reference
Service
Business Development Services | Cell Therapy Manufacturing and Process Development
Clearbridge Medical Group
Singapore
C
11-50 Employees
-
Key takeaway
The company is focused on developing efficient solutions for early disease detection and personalized chronic disease management, which may relate to advancements in therapeutic approaches like bispecific antibodies.
Reference
Product
BioTech Corp - Bio Nexus | Clearbridge Medical Group
PrintBioTech Corp - Bio Nexus
Jubilant Pharma
Singapore
C
1-10 Employees
-
Key takeaway
The company, Jubilant Pharma, has a strong background in developing and producing pharmaceuticals, including a diverse range of allergy therapy products. Their expertise in manufacturing and commitment to advancing medical practices, particularly in immunotherapy and nuclear medicine, highlights their role in the healthcare industry.
Reference
Core business
Bioptimal International Pte. Ltd.
Singapore
C
501-1000 Employees
1987
Key takeaway
Bioptimal International has successfully developed several medical products, including a Bipolar Pacing Catheter and a thermodilution catheter, which highlights the company's commitment to innovation in the medical field. Their products have received various approvals, ensuring quality and compliance with international standards.
Reference
Core business
Bioptimal
iX Biopharma
Singapore
C
51-100 Employees
2000
Key takeaway
The company, iX Biopharma Ltd, focuses on developing innovative therapies that enhance the quality of life for patients with chronic diseases and pain. They utilize their proprietary WaferiX technology to deliver therapeutic molecules, such as NAD+, directly into the bloodstream, which highlights their commitment to advanced drug delivery methods.
Reference
Core business
iX Biopharma
ARISTA Biotech Pte. Ltd.
Singapore
C
11-50 Employees
2020
Key takeaway
The company is focused on providing innovative and affordable COVID-19 testing solutions, including the ARISTA® COVID-19 Neutralizing Antibody Test. Their expertise in the pharmaceutical industry supports high-quality product development and strategic collaborations.
Reference
Core business
ARISTA® Biotech – COVID-19 Test Kits
Technologies which have been searched by others and may be interesting for you:
In Singapore, the bispecific antibody industry is shaped by several key considerations for those looking to enter or research the field. The regulatory environment is critical, as the Health Sciences Authority (HSA) oversees the approval and commercialization of biopharmaceuticals, requiring compliance with stringent quality and safety standards. Researchers and companies must navigate the complexities of clinical trials, which are essential for demonstrating efficacy and safety. The competitive landscape includes both local biotech firms and multinational corporations, which necessitates an understanding of market positioning and innovation strategies. Singapore's emphasis on R&D and biotechnology investment creates significant opportunities, bolstered by government initiatives aimed at fostering innovation in life sciences. However, challenges such as high operational costs and talent acquisition in specialized fields persist. Environmental concerns are increasingly relevant, particularly in terms of sustainable practices in biomanufacturing and waste management. Additionally, the global market for bispecific antibodies is expanding, driven by their potential in treating complex diseases like cancer and autoimmune disorders. With Singapore's strategic location and robust healthcare infrastructure, the region is poised to play a significant role in the development and commercialization of these advanced therapeutics, making it an attractive destination for investors and researchers alike.
Some interesting numbers and facts about your company results for Bispecific Antibody
| Country with most fitting companies | Singapore |
| Amount of fitting manufacturers | 21 |
| Amount of suitable service providers | 11 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1987 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Bispecific Antibody
What are related technologies to Bispecific Antibody?
Based on our calculations related technologies to Bispecific Antibody are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bispecific Antibody?
The most represented industries which are working in Bispecific Antibody are Biotechnology, Healthcare, Medical, Finance and Insurance, Food and Beverage
How does ensun find these Bispecific Antibody Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.